mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.001 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.001 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.002 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |